Report: U.S. Genetic Diagnostics Markets TOC

1. Executive Summary
- 1. Executive Summary
  - 1. Market Overview
2. Total Market
- 1. Market Overview
  - 1. U.S. Genetic Diagnostics Market Introduction
  - 2. Market Definition and Segmentation Overview
  - 3. Research Methodology
- 2. Market Analysis
  - 1. Market Engineering Measurements
  - 2. Industry Challenges
  - 3. Strategic Recommendations
  - 4. Regulatory Issues
- 3. Competitive Analysis
  - 1. Competitive Structure and Market Share Analysis
  - 2. Platform Comparison
  - 3. End-user Profiles
- 4. Market Forecasts
  - 1. Revenue Forecast
3. Pharmacogenomic Testing Market
- 1. Market Overview
  - 1. Introduction
  - 2. Market Definition
- 2. Product Analysis
  - 1. P450 and HER-2 Pharmacogenomic Tests
  - 2. Cytochrome P450 Drug Interaction
  - 3. Other Prominent Pharmacogenomic Tests
  - 4. CYP450 Testing Platform Comparison
- 3. Market Analysis
  - 1. Market Engineering Analysis
  - 2. Pharmacogenomic Testing Market Drivers
  - 3. Market Restraints
- 4. Competitive Analysis
  - 1. Competitive Landscape Structure
  - 2. Market Share Analysis
  - 3. Customer Analysis
  - 4. Market Impact Analysis
- 5. Market Forecasts
  - 1. Revenue Forecast
4. Prenatal and Newborn Genetic Screening Market
- 1. Market Overview
  - 1. Market Overview
  - 2. Market Definition
- 2. Market Analysis
  - 1. Market Engineering Measurements
  - 2. Market Drivers
  - 3. Market Restraints
- 3. Competitive Analysis
  - 1. Product Analysis
  - 2. Competitive Structure and Market Share Analysis
- 4. Market Forecasts
  - 1. Revenue Forecast
5. Predictive Medicine Market
- 1. Market Overview
  - 1. Introduction
  - 2. Market Definition
- 2. Competitive Analysis
  - 1. Predisposition and Diagnostic Products
  - 2. Competitive Structure and Market Share Analysis
- 3. Market Analysis
  - 1. Market Measurements
  - 2. Market Drivers
  - 3. Market Restraints
- 4. Market Forecasts
  - 1. Revenue Forecast
6. Decision Support Database
- 1. Supporting Statistical Data
  - 1. Number and Types of Genetic Tests
  - 2. Pharmacogenomic Information
Chapter 2
- Total Genetic Diagnostic Market: Impact of Top Industry Challenges (U.S.), 2004-2011
- Total Genetic Diagnostic Market: Impact of Top Industry Challenges on Business Function (U.S.), 2004-2011
- Total Genetic Diagnostic Market: Strategic Recommendations (U.S.), 2004
- Total Genetic Diagnostic Market: Competitive Structure (U.S.), 2004
- Total Genetic Diagnostic Market: Products Offered by Major Market Participants (U.S.), 2004
- Total Genetic Diagnostic Market: Revenue Forecasts (U.S.), 2001-2011.
Chapter 3
- Pharmacogenomic Testing Market: List of CYP450 Isoform Drug Interaction (U.S.), 2004
- Pharmacogenomic Testing Market: Product Analysis (U.S.), 2004
- Pharmacogenomic Testing Market: Market Drivers Ranked In Order of Impact (U.S.), 2004-2011
- Pharmacogenomic Testing Market: Market Restraints Ranked In Order of Impact (U.S.), 2004-2011
- Pharmacogenomic Testing Market: Competitive Structure (U.S.), 2004
- Pharmacogenomic Testing Market: Products Offered by Major Market
- Pharmacogenomic Testing Market: Drugs Pulled from Market Due to Adverse Reactions (U.S.), 2004
- Pharmacogenomic Testing Market: Revenue Forecasts (U.S.) 2001-2011
Chapter 4
- Prenatal and Newborn Genetic Screening Market: Market Drivers (U.S.), 2004-2011
- Prenatal and Newborn Genetic Screening Market: Risk of Downs Syndrome vs. Maternal Age (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: Market Restraints (U.S.), 2004-2011
- Prenatal and Newborn Genetic Screening Market: Products Offered by Major Market Participants (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: Common Tests for Each Subsegment (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: Competitive Structure (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: State Newborn Screening Programs (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: Revenue Forecasts (U.S.), 2004
Chapter 5
- Predictive Medicine Market: Products Offered by Major Market Participants (U.S.), 2004
- Predictive Medicine Market: Competitive Structure (U.S.), 2004
- Predictive Medicine Market: Market Drivers (U.S.), 2004-2011
- Predictive Medicine Market: Market Restraints (U.S.), 2004-2011
- Predictive Medicine Market: Revenue Forecasts (U.S.), 2001-2011
Chapter 6
- Decision Support Database: Number and Type of Genetic Tests (U.S.), 2004
- Decision Support Database: Safety Based Drug Withdrawals (U.S.), 2004
- Decision Support Database: Most Prescribed Drugs (U.S.) 2004
- Decision Support Database: Top Revenue Generating Drugs (U.S.) 2004
List of Charts
Chapter 2
- Total Genetic Diagnostics Market: Percent Revenues by Segment (U.S.), 2004
- Total Genetic Diagnostics Market: Market Engineering Measurements (U.S.), 2004
- Total Genetic Diagnostics Market: Competitive Structure (U.S.), 2004
- Total Genetic Diagnostics Market: Company Market Share Revenue (U.S.), 2004
- Total Genetic Diagnostics Market: Technology Life Cycle (U.S.), 2004
- Total Genetic Diagnostics Market: Revenue Forecasts (U.S.), 2001-2011
- Total Genetic Diagnostics Market: Revenue Forecasts by Segment (U.S.), 2001-2011
Chapter 3
- Pharmacogenomic Testing Market: Market Engineering Measurements (U.S.), 2004
- Pharmacogenomic Testing Market: Competitive Structure (U.S.), 2004
- Pharmacogenomic Testing Market: Test Market Share (U.S.), 2004
- Pharmacogenomic Testing Market: Effect of Testing on Market Size of Drug (U.S.), 2004-2011
- Pharmacogenomic Testing Market: Revenue Forecasts (U.S.), 2001-2011
Chapter 4
- Prenatal and Newborn Genetic Screening Market: Market Engineering Measurements (U.S.), 2004
- Prenatal and Newborn Genetic Screening Market: Revenue Forecasts (U.S.), 2001-2011
Chapter 5
- Predictive Medicine Market: Market Engineering Measurements (U.S.) 2004
- Predictive Medicine Market: Revenue Forecasts (U.S.), 2001-2011

U.S. Genetic Diagnostics Markets

Table of Contents